SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-089229
Filing Date
2023-11-21
Accepted
2023-11-21 15:58:21
Documents
14
Period of Report
2023-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188842-8k_elevailabs.htm   iXBRL 8-K 31255
2 UNDERWRITING AGREEMENT DATED NOVEMBER 20, 2023, BY AND AMONG ELEVAI LABS INC., U ea188842ex1-1_elevailabs.htm EX-1.1 322305
3 PRESS RELEASE OF THE COMPANY DATED AS OF NOVEMBER 20, 2023 ea188842ex99-1_elevailabs.htm EX-99.1 13585
  Complete submission text file 0001213900-23-089229.txt   628404

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20231120.xsd EX-101.SCH 3030
5 XBRL LABEL FILE elab-20231120_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE elab-20231120_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT ea188842-8k_elevailabs_htm.xml XML 3412
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 231427886
SIC: 2834 Pharmaceutical Preparations